RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1 - PubMed (original) (raw)
. 2004 Aug;19(8):1339-48.
doi: 10.1359/JBMR.040321. Epub 2004 Mar 29.
Affiliations
- PMID: 15231022
- DOI: 10.1359/JBMR.040321
Free article
RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1
Uma Sankar et al. J Bone Miner Res. 2004 Aug.
Free article
Abstract
The coordination of cell cycle progression and osteoclast differentiation by RANKL signaling was studied. Experiments with mouse genetic models revealed that RANKL promoted cell cycle withdrawal of osteoclast precursors dependent on the cyclin kinase inhibitor p27-KIP1, but that both p27-KIP1 and p21-CIP1 were required for osteoclast differentiation. These cyclin inhibitors may directly regulate osteoclast differentiation in addition to regulating cell cycle withdrawal.
Introduction: RANKL stimulates mononuclear precursor cells of the myeloid lineage to differentiate into multinuclear osteoclasts, thus providing a system to study the fundamental problem of coordination of cell cycle progression with cell differentiation.
Materials and methods: Mice that lack expression of functional cyclin inhibitors p27KIP1and p21CIP1 were used to study cell cycle progression and differentiation of osteoclast precursors in vitro and in vivo.
Results and conclusions: Experiments with cells derived from p27KIP1- and p21CIP1-deficient mice indicated that p27KIP1 function alone was necessary for RANKL-mediated cell cycle withdrawal by osteoclast precursors, but osteoclasts from mice with single mutations in either of these two genes differentiated normally. In contrast, p21/p27 double knockout mice developed osteopetrosis, with fewer osteoclasts that exhibited lower TRACP activity and abnormal cell morphology present in long bone. Moreover, isolated osteoclast progenitors from p21/p27 double knockout mice were defective in RANKL-mediated differentiation in vitro, expressing low levels of osteoclast-specific genes like TRACP and cathepsin K. Taken together, these data suggest p27KIP1 and p21CIP1 play roles in osteoclast differentiation in response to RANKL signaling distinct from their roles in promoting cell cycle withdrawal.
Similar articles
- Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.
Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T. Kobayashi K, et al. J Exp Med. 2000 Jan 17;191(2):275-86. doi: 10.1084/jem.191.2.275. J Exp Med. 2000. PMID: 10637272 Free PMC article. - The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation.
Lee SE, Woo KM, Kim SY, Kim HM, Kwack K, Lee ZH, Kim HH. Lee SE, et al. Bone. 2002 Jan;30(1):71-7. doi: 10.1016/s8756-3282(01)00657-3. Bone. 2002. PMID: 11792567 - Osteoclast differentiation is associated with transient upregulation of cyclin-dependent kinase inhibitors p21(WAF1/CIP1) and p27(KIP1).
Okahashi N, Murase Y, Koseki T, Sato T, Yamato K, Nishihara T. Okahashi N, et al. J Cell Biochem. 2001;80(3):339-45. J Cell Biochem. 2001. PMID: 11135363 - Stopping and going with p27kip1.
Assoian RK. Assoian RK. Dev Cell. 2004 Apr;6(4):458-9. doi: 10.1016/s1534-5807(04)00103-0. Dev Cell. 2004. PMID: 15068785 Review. - Cdk2 as a master of S phase entry: fact or fake?
Aleem E, Berthet C, Kaldis P. Aleem E, et al. Cell Cycle. 2004 Jan;3(1):35-7. Cell Cycle. 2004. PMID: 14657662 Review.
Cited by
- RNA therapeutics targeting osteoclast-mediated excessive bone resorption.
Wang Y, Grainger DW. Wang Y, et al. Adv Drug Deliv Rev. 2012 Sep;64(12):1341-57. doi: 10.1016/j.addr.2011.09.002. Epub 2011 Sep 10. Adv Drug Deliv Rev. 2012. PMID: 21945356 Free PMC article. Review. - Involvement of Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-induced Incomplete Cytokinesis in the Polyploidization of Osteoclasts.
Takegahara N, Kim H, Mizuno H, Sakaue-Sawano A, Miyawaki A, Tomura M, Kanagawa O, Ishii M, Choi Y. Takegahara N, et al. J Biol Chem. 2016 Feb 12;291(7):3439-54. doi: 10.1074/jbc.M115.677427. Epub 2015 Dec 15. J Biol Chem. 2016. PMID: 26670608 Free PMC article. - Inhibition of Ca²⁺/calmodulin-dependent protein kinase kinase 2 stimulates osteoblast formation and inhibits osteoclast differentiation.
Cary RL, Waddell S, Racioppi L, Long F, Novack DV, Voor MJ, Sankar U. Cary RL, et al. J Bone Miner Res. 2013 Jul;28(7):1599-610. doi: 10.1002/jbmr.1890. J Bone Miner Res. 2013. PMID: 23408651 Free PMC article. - Identification of Novel Genes for Cell Fusion during Osteoclast Formation.
Cho E, Cheon S, Ding M, Lim K, Park SW, Park C, Lee TH. Cho E, et al. Int J Mol Sci. 2022 Jun 8;23(12):6421. doi: 10.3390/ijms23126421. Int J Mol Sci. 2022. PMID: 35742859 Free PMC article. - Mouse mandibular-derived osteoclast progenitors have differences in intrinsic properties compared with femoral-derived progenitors.
Clark R, Park SY, Bradley EW, Mansky K, Tasca A. Clark R, et al. JBMR Plus. 2024 Mar 4;8(5):ziae029. doi: 10.1093/jbmrpl/ziae029. eCollection 2024 May. JBMR Plus. 2024. PMID: 38606149 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous